Calithera Biosciences (NASDAQ:CALA) reported $3.00 million in sales this quarter. This is the same as the same period last year.
Calithera Biosciences Q2 Sales $3.00M, Same YoY
Calithera Biosciences (NASDAQ:CALA) reported $3.00 million in sales this quarter. This is the same as the same period last year.
Related Posts
Workday To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Monday
August 28, 7:50 AM
Truist Securities raised the price target for Church & Dwight Co., Inc. (NYSE: CHD) from $95 to $105. Truist Securities analyst Bill Chappell upgraded the stock from Hold to Buy. Church & Dwight shares gained 0.5% to close at $93.30 on Friday.
Las Vegas Sands Stock Trades Higher After Hours On ‘Robust Recovery’ In Travel, Gaming
April 19, 4:40 PM
Las Vegas Sands Corp (NYSE: LVS) shares are rising in extended trading Wednesday after the company reported first-quarter results that topped analyst exp
BlackRock, Fidelity Outperform Grayscale’s GBTC: 2 Key Metrics Where Rivals Have An Edge
February 8, 10:07 AM
Spot Bitcoin (CRYPTO: BTC) exchange-traded funds (ETFs) offered by BlackRock Inc. (NYSE: BLK) and Fidelity are outperforming